8-K 1 wellacvr.txt WELLA 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 18, 2003 THE PROCTER & GAMBLE COMPANY -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 -------------------------------------------------------------------------------- (State or other (Commission File Number) (IRS Employer jurisdiction of Identification incorporation) Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 -------------- ITEM 9. REGULATION FD DISCLOSURE On March 18, 2003, The Procter & Gamble Company (the "Company") issued a news release announcing that the Company has signed an agreement to purchase a controlling interest from the majority shareholders of Wella AG, headquartered in Darmstadt, Germany. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. THE PROCTER & GAMBLE COMPANY /s/SHARON E. ABRAMS ------------------------------------ Sharon E. Abrams, Secretary March 18, 2003 Exhibit 99. News Release by The Procter & Gamble Company dated March 18, 2003.